China approves Sinovac jabs for general public use

International Desk
6 February 2021, Sat
Published: 08:43 Updated: 08:44

China approves Sinovac jabs for general public use

Sinovac Biotech said on Saturday that its unit’s Covid-19 vaccine has been formally approved for use by the general public by China’s medical products regulator.

It marks the second Covid-19 vaccine greenlighted for public use in China, after a shot developed by a Beijing institute affiliated to state-owned China National Pharmaceutical Group (Sinopharm) was approved in December.

Prior to the approvals, both vaccines have already been used in China’s vaccination programme mainly targeting key groups deemed to be at higher risk of exposure to the virus.

Indonesia, Turkey, Brazil, Chile, Colombia, Uruguay, and Laos have granted emergency authorizations for the CoronaVac vaccine developed by Sinovac Life Sciences, Sinovac said in a news release. According to Reuters reports.

Sinovac also said that the approval is based on the two-month results from late-stage clinical trials overseas, from which the final analysis data has not yet been obtained.